American Portfolios Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$90.8K Sell
740
-26
-3% -$3.42K ﹤0.01% 1409
2022
Q2
$102K Sell
766
-168
-18% -$22.9K ﹤0.01% 1388
2022
Q1
$128K Buy
934
+242
+35% +$33.7K ﹤0.01% 1390
2021
Q4
$120K Buy
692
+4
+0.6% +$609 ﹤0.01% 1426
2021
Q3
$100K Sell
688
-19
-3% -$2.78K ﹤0.01% 1453
2021
Q2
$93.3K Buy
707
+53
+8% +$6.94K ﹤0.01% 1454
2021
Q1
$83.9K Buy
654
+373
+133% +$46K ﹤0.01% 1390
2020
Q4
$33.5K Buy
281
+240
+585% +$29.3K ﹤0.01% 1576
2020
Q3
$4.69K Sell
41
-35
-46% -$4.13K ﹤0.01% 2314
2020
Q2
$8.66K Sell
76
-37
-33% -$3.92K ﹤0.01% 1984
2020
Q1
$9.07K Sell
113
-66
-37% -$6.83K ﹤0.01% 1852
2019
Q4
$19.1K Hold
179
﹤0.01% 1745
2019
Q3
$19.2K Sell
179
-111
-38% -$11.4K ﹤0.01% 1677
2019
Q2
$29.5K Buy
+290
New +$27.9K ﹤0.01% 1495
2018
Q4
Sell
-70
Closed -$7.55K 2441
2018
Q3
$7.55K Hold
70
﹤0.01% 1838
2018
Q2
$7.7K Hold
70
﹤0.01% 1823
2018
Q1
$7.02K Buy
+70
New +$7.17K ﹤0.01% 1751

Other funds holding DGX

American Portfolios Advisors's DGX Position: Q3 2022 in Review

American Portfolios Advisors reduced its Quest Diagnostics (DGX) stake by 3.4% in Q3 2022, selling an estimated $3.42K and leaving 740 shares worth $90.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

American Portfolios Advisors first reported a position in DGX in Q1 2018 and has held it in 17 quarters since. The position peaked at $128K in Q1 2022. 809 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • American Portfolios Advisors held 740 shares of Quest Diagnostics worth $90.8K as of Q3 2022.
  • American Portfolios Advisors sold 26 Quest Diagnostics shares in Q3 2022, an estimated $3.42K.
  • Quest Diagnostics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1409 holding.
  • American Portfolios Advisors first reported a position in Quest Diagnostics in Q1 2018 and has held it in 17 quarters since.
  • American Portfolios Advisors's Quest Diagnostics position peaked at $128K in Q1 2022.
  • 809 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.